Journal of Clinical Review & Case Reports(JCRC)
ISSN: 2573-9565 | DOI: 10.33140/JCRC
Impact Factor: 1.823
Researchers and authors can directly submit their manuscript online through this link Online Manuscript Submission.
The Allergenic Role of the Drug Excipient in a Case of Allergy in Pcsk-9 Inhibitor
Abstract
Salihu Kushtrim and Abdullahu Valon
Hyperlipidemia is a well-established risk factor for the development of cardiovascular disease (CVD) [1]. Proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors are novel drugs in use against hyperlipidemia [2].